Regen Biologics 545 Penobscot Dr, Redwood City, CA94063 Established in 1990, Regen Biologics develops and manufactures orthopedic products with the aim of helping individuals…More continue an active lifestyle after sustaining torn cartilage. This is the company's manufacturing facility.
Star Publishing 650 El Camino Real, Redwood City, CA94063 Star Publishing is a private publishing house that was established in 1978. The company specializes in…More publishing textbooks and reference books in accounting, biology, earth sciences, the environment and geology.
Facet Biotech Corporation 1400 Seaport Blvd, Redwood City, CA94063 The Facet Biotech Corporation researches and develops biotechnology for the medical community. The company has a…More biology-driven approach to research and is focused on discovering and developing new drugs.
Beth Cold Acupuncturist 1121 Jefferson Ave, Redwood City, CA94063 Beth Cold Acupuncturist is a Redwood City based acupuncturist and herbalist. The services provided are designed to treat…More conditions affecting the immune system through rubs, ointments and dietary supplements. Acupuncture services are intended to treat behavioral conditions, curb cravings and affect changes in the biological chemistry of patients.
Valley Medical Oncology Consultants 2940 Whipple Ave, Redwood City, CA94062 The Valley Medical Oncology Consultants offer top-notch physicians and nurses specializing in hematology and oncology…More care. The group has several centers around the San Francisco Bay Area, including on one Whipple Avenue in Redwood City. Chemotherapy and biology therapy infusions are given at this location. The facilities are state-of-the-art.
OncoMed Pharmaceutical 800 Chesapeake Dr, Redwood City, CA94063 OncoMed is a Redwood City-based company that was established in 2004. This biotechnology company is focused on improving…More cancer treatment by developing antibodies that target biological pathways known as cancer stem cells. In November 2010, OncoMed was awarded five grants that totaled $1.2 million, which will be used to continue five therapeutic programs. The company's website chronicles its research and posts recent relevant news.